Protocol Ledger

NCT04634578 · Phase II · ACTIVE NOT RECRUITING

Bevacizumab Treatment For Type 1 ROP

Interventional Phase II clinical trial protocol NCT04634578 sponsored by Jaeb Center for Health Research in Ophthalmology and Sensory, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-05-01 Enrollment: 77 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04634578
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)77 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04634578
Protocol FieldVerified Registry Value
NCT IdentifierNCT04634578
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortOphthalmology and Sensory
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment77 participants (ACTUAL)
Registered Start Date2022-05-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI